par Oettle, H;Richards, D.;Ramanathan, R K;Van Laethem, Jean-Luc ;Peeters, Marc;Fuchs, M;Zimmermann, A;John, W;Von Hoff, D D;Arning, M;Kindler, H L
Référence Annals of oncology, 16, 10, page (1639-1645)
Publication Publié, 2005-10
Référence Annals of oncology, 16, 10, page (1639-1645)
Publication Publié, 2005-10
Article révisé par les pairs
Titre: |
|
Auteur: | Oettle, H; Richards, D.; Ramanathan, R K; Van Laethem, Jean-Luc; Peeters, Marc; Fuchs, M; Zimmermann, A; John, W; Von Hoff, D D; Arning, M; Kindler, H L |
Informations sur la publication: | Annals of oncology, 16, 10, page (1639-1645) |
Statut de publication: | Publié, 2005-10 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Gemcitabine |
Pancreatic cancer | |
Pemetrexed | |
Phase III | |
Survival | |
MeSH keywords: | Adult |
Aged | |
Aged, 80 and over | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Deoxycytidine -- administration & dosage -- analogs & derivatives -- therapeutic use | |
Female | |
Glutamates -- administration & dosage | |
Guanine -- administration & dosage -- analogs & derivatives | |
Humans | |
Infusions, Intravenous | |
Male | |
Middle Aged | |
Neoplasm Metastasis | |
Neutropenia -- chemically induced | |
Pancreatic Neoplasms -- drug therapy -- pathology | |
Survival Analysis | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase III |
Comparative Study | |
Journal Article | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdi309 | |
info:pii/mdi309 | |
info:scp/27144530079 | |
info:pmid/16087696 |